Routine deprescribing of chronic medications to combat polypharmacy

Therapeutic Advances in Drug Safety

Volumn 6, Issue 6, 2015, Pages 212-233

  Garfinkel, Doron ^a   Ilhan, Birkan ^b   Bahat, Gulistan ^b  

^a Israel Cancer Association   (Israel)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Comorbidity; Dementia; Frailty; Geriatric Palliative; IGRIMUP; Inappropriate Medication Use; Limited Life expectancy; Polypharmacy

Indexed keywords

AGING; COGNITIVE DEFECT; COMORBIDITY; COMPUTER AIDED DESIGN; DEMENTIA; DRUG DRUG INTERACTION; DRUG INTERACTION; DRUG USE; EDUCATION PROGRAM; FALLING; HEALTH PROGRAM; HIP FRACTURE; HOSPITALIZATION; HUMAN; INAPPROPRIATE MEDICATION USE; INAPPROPRIATE PRESCRIBING; LIFE EXPECTANCY; LONG TERM CARE; MORTALITY; NURSING HOME PATIENT; OUTCOME ASSESSMENT; PATIENT CARE; POLYPHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SOCIAL STATUS; WEIGHT REDUCTION;

EID: 84948693753     PISSN: 20420986     EISSN: 20420994     Source Type: Journal    
DOI: 10.1177/2042098615613984     Document Type: Review

References (164)

1. Ahmed B. Nanji K. Mujeeb R. Patel M. (2014) Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study. PLoS One 9: e112133.
2. Akamine D. Filho M. Peres C. (2007) Drug–nutrient interactions in elderly people. Curr Opin Clin Nutr Metab Care 10: 304–310.
3. Akazawa M. Imai H. Igarashi A. Tsutani K. (2010) Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother 8: 146–160.
4. Alagiakrishnan K. Wiens C. (2004) An approach to drug induced delirium in the elderly. Postgrad Med J 80: 388–393.
5. Anderson K. Stowasser D. Freeman C. Scott I. (2014) Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open 4: e006544.
6. Avorn J. Soumerai S. Everitt D. Ross-Degnan D. Beers M. Sherman D. (1992) A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 327: 168–173.
7. Barry P. Gallagher P. Ryan C. O–Mahony D. (2007) START (Screening Tool to Alert Doctors to the Right Treatment) – an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 36: 632–638.
8. Barry P. O–Keefe N. O–Connor K. O–Mahony D. (2006) Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the Improved Prescribing in the Elderly Tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther 31: 617–626.
9. Basger B. Chen T. Moles R. (2008) Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging 25: 777–793.
10. Basger B. Chen T. Moles R. (2012) Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method. BMJ Open 2: 1–20.
11. Beers M. (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 157: 1531–1536.
12. Beers M. Ouslander J. Rollingher I. Reuben D. Brooks J. Beck J. (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151: 1825–1832.
13. Bottiggi K. Salazar J. Yu L. Caban-Holt A. Ryan M. Schmitt F. (2007) Concomitant use of medications with anticholinergic properties and acetylcholinesterase inhibitors: impact on cognitive and physical functioning in Alzheimer disease. Am J Geriatr Psychiatry 15: 357–359.
14. Boyd C. Darer J. Boult C. Fried L. Boult L. Wu A. (2005) Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 294: 716–724.
15. Bregnhoj L. Thirstrup S. Kristensen M. Bjerrum L. Sonne J. (2009) Combined intervention programme reduces inappropriate prescribing in elderly patients exposed to polypharmacy in primary care. Eur J Clin Pharmacol 65: 199–207.
16. Budnitz D. Lovegrove M. Shehab N. Richards C. (2011) Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 365: 2002–2012.
17. Budnitz D. Shehab N. Kegler S. Richards C. (2007) Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 147: 755–765.
18. Chiu M. Lee H. Hwang H. Wang S. Lin M. (2014) Medication use and fall-risk assessment for falls in an acute care hospital. Geriatr Gerontol Int 15: 856–863.
19. Conn V. Hafdahl A. Cooper P. Ruppar T. Mehr D. Russell C. (2009) Interventions to improve medication adherence among older adults: meta-analysis of adherence outcomes among randomized controlled trials. Gerontologist 49: 447–462.
20. Cooper J. (1999) Adverse drug reaction-related hospitalizations of nursing facility patients: a 4-year study. South Med J 92: 485–490.
21. Crotty M. Halbert J. Rowett D. Giles L. Birks R. Williams H. (2004) An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 33: 612–617.
22. Cruz-Jentoft A. Boland B. Rexach L. (2012) Drug therapy optimization at the end of life. Drugs Aging 29: 511–521.
23. Curtain C. Bindoff I. Westbury J. Peterson G. (2013) A comparison of prescribing criteria when applied to older community-based patients. Drugs Aging 30: 935–943.
24. Doan J. Zakrzewski-Jakubiak H. Roy J. Turgeon J. Tannenbaum C. (2013) Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Ann Pharmacother 47: 324–332.
25. Drenth-Van Maanen A. Van Marum R. Knol W. Van Der Linden C. Jansen P. (2009) Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging 26: 687–701.
26. Eide E. Schjott J. (2001) Assessing the effects of an intervention by a pharmacist on prescribing and administration of hypnotics in nursing homes. Pharm World Sci 23: 227–231.
27. Ernst F. Grizzle A. (2001) Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 41: 192–199.
28. Fick D. Semla T. Beizer J. Brandt N. Dombrowski R. Dubeau C. (2012) American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60: 616–631.
29. Fick D. Cooper J. Wade W. Waller J. Maclean J. Beers M. (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163: 2716–2724.
30. Fossey J. Ballard C. Juszczak E. James I. Alder N. Jacoby R. (2006) Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ 332: 756–761.
31. Fowler C. Cowburn R. Joseph J. (1997) Alzheimer–s, ageing and amyloid: an absurd allegory? Gerontology 43: 132–142.
32. Frazier S. (2005) Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 31: 4–11.
33. Gaddey H. Holder K. (2014) Unintentional weight loss in older adults. Am Fam Physician 89: 718–722.
34. Gallagher P. O–Mahony D. (2008) STOPP (Screening Tool of Older Persons– Potentially Inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers– criteria. Age Ageing 37: 673–679.
35. Gallagher P. Ryan C. Byrne S. Kennedy J. O–Mahony D. (2008) STOPP (Screening Tool of Older Person–s Prescriptions) and START (Screening Tool to Alert Doctors to Right Treatment). consensus validation. Int J Clin Pharmacol Ther 46: 72–83.
36. Gallagher P. O–Connor M. O–Mahony D. (2011) Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 89: 845–854.
37. Garfinkel D. (1997) Geriatric boom catastrophe – a major medical, economic and social nightmare of the 21st century. Proceedings of the 16th Congress of the International Association of Gerontology, 18–23 August 1997, Adelaid, Australia.
38. Garfinkel D. (2013) The tsunami in 21st century healthcare: the age-related vicious circle of co-morbidity – multiple symptoms – over-diagnosis – over treatment-polypharmacy. J Nutr Health Aging 17(Suppl. 1): SS24, 227-C1, S96-7.
39. Garfinkel D. (2014) Digital methods for medication review – less is more – customizing drug therapy in the elderly. Eur Union Geriatr Med 5(Suppl. 1): S22–S23. doi:http://dx.doi.org/10.1016/S1878-7649(14)70055-5
40. Garfinkel D. Mangin D. (2010) Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 170: 1648–1654.
41. Garfinkel D. Zur-Gil S. Ben-Israel J. (2007) The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 9: 430–434.
42. Gellad W. Grenard J. Marcum Z. (2011) A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 9: 11–23.
43. Ghibelli S. Marengoni A. Djade C. Nobili A. Tettamanti M. Franchi C. (2013) Prevention of inappropriate prescribing in hospitalized older patients using a computerized prescription support system (INTERcheck(®). Drugs Aging 30: 821–828.
44. Gill S. Mamdani M. Naglie G. Streiner D. Bronskill S. Kopp A. (2005) A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med 165: 808–813.
45. Gnjidic D. Hilmer S. Blyth F. Naganathan V. Cumming R. Handelsman D. (2012a) High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther 91: 521–528.
46. Gnjidic D. Le Couteur D. Abernethy D. Hilmer S. (2012b) Drug burden index and Beers criteria: impact on functional outcomes in older people living in self-care retirement villages. J Clin Pharmacol 52: 258–265.
47. Gnjidic D. Le Couteur D. Pearson S. McLachlan A. Viney R. Hilmer S. (2013) High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health 13: 115.
48. Gomez C. Vega-Quiroga S. Bermejo-Pareja F. Medrano M. Louis E. Benito-Leon J. (2014) Polypharmacy in the elderly: a marker of increased risk of mortality in a population-based prospective study (NEDICES). Gerontology 61: 301–309.
49. Gormley E. Griffiths D. McCracken P. Harrison G. (1993) Polypharmacy and its effect on urinary incontinence in a geriatric population. Br J Urol 71: 265–269.
50. Gurwitz J. Field T. Harrold L. Rothschild J. Debellis K. Seger A. (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289: 1107–1116.
51. Hamilton H. Gallagher P. Ryan C. Byrne S. O–Mahony D. (2011) Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 171: 1013–1019.
52. Hanlon J. Schmader K. Koronkowski M. Weinberger M. Landsman P. Samsa G. (1997) Adverse drug events in high risk older outpatients. J Am Geriatr Soc 45: 945–948.
53. Hanlon J. Schmader K. Samsa G. Weinberger M. Uttech K Lewis I. (1992) A method for assessing drug therapy appropriateness. J Clin Epidemiol 45: 1045–1051.
54. Haque R. (2009) Armor: a tool to evaluate polypharmacy in elderly persons. Ann Longterm Care 17: 26–30. Available at: http://www.annalsoflongtermcare.com/content/armor-a-tool-evaluate-polypharmacy-elderly-persons
55. Hatanpaa K. Isaacs K. Shirao T. Brady D. Rapoport S. (1999) Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. J Neuropathol Exp Neurol 58: 637–643.
56. Haynes R. Ackloo E. Sahota N. McDonald H. Yao X. (2008) Interventions for enhancing medication adherence. Cochrane Database Syst Rev CD000011.
57. Heuberger R. Caudell K. (2011) Polypharmacy and nutritional status in older adults: a cross-sectional study. Drugs Aging 28: 315–323.
58. Hilmer S. Mager D. Simonsick E. Cao Y. Ling S. Windham B. (2007) A drug burden index to define the functional burden of medications in older people. Arch Intern Med 167: 781–787.
59. Hilmer S. Mager D. Simonsick E. Ling S. Windham B. Harris T. (2009) Drug burden index score and functional decline in older people. Am J Med 122: 1142–1149.
60. Holmes H. Hayley D. Alexander G. Sachs G. (2006) Reconsidering medication appropriateness for patients late in life. Arch Intern Med 166: 605–609.
61. Holt S. Schmiedl S. Thurmann P. (2010) Potentially inappropriate medications in the elderly: the Priscus List. Dtsch Arztebl Int 107: 543–551.
62. Hoonhout L. De Bruijne M. Wagner C. Zegers M. Waaijman R. Spreeuwenberg P. (2009) Direct medical costs of adverse events in Dutch hospitals. BMC Health Serv Res 9: 27.
63. Hovstadius B. Petersson G. (2013) The impact of increasing polypharmacy on prescribed drug expenditure – a register-based study in Sweden 2005–2009. Health Policy 109: 166–174.
64. Jano E. Aparasu R. (2007) Healthcare outcomes associated with Beers– criteria: a systematic review. Ann Pharmacother 41: 438–447.
65. Jensen G. Kita K. Fish J. Heydt D. Frey C. (1997) Nutrition risk screening characteristics of rural older persons: relation to functional limitations and health care charges. Am J Clin Nutr 66: 819–828.
66. Juurlink D. Mamdani M. Kopp A. Laupacis A. Redelmeier D. (2003) Drug–drug interactions among elderly patients hospitalized for drug toxicity. JAMA 289: 1652–1658.
67. Jyrkka J. Enlund H. Lavikainen P. Sulkava R. Hartikainen S. (2011) Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf 20: 514–522.
68. Kashyap M. Belleville S. Mulsant B. Hilmer S. Paquette A. Tu Le M. (2014) Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline. J Am Geriatr Soc 62: 336–341.
69. Kaufman D. Kelly J. Rosenberg L. Anderson T. Mitchell A. (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287: 337–344.
70. Kelly J. Kaufman D. Kelley K. Rosenberg L. Anderson T. Mitchell A. (2005) Recent trends in use of herbal and other natural products. Arch Intern Med 165: 281–286.
71. Kersten H. Molden E. Tolo I. Skovlund E. Engedal K. Wyller T. (2012) Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial. J Gerontol A: Biol Sci Med Sci 68: 271–278.
72. Klarin I. Wimo A. Fastbom J. (2005) The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 22: 69–82.
73. Lai S. Liao K. Liao C. Muo C. Liu C. Sung F. (2010) Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore) 89: 295–299.
74. Lapane K. Hughes C. Daiello L. Cameron K. Feinberg J. (2011) Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes. J Am Geriatr Soc 59: 1238–1245.
75. Laroche M. Charmes J. Merle L. (2007) Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 63: 725–731.
76. Larson E. Kukull W. Buchner D. Reifler B. (1987) Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 107: 169–173.
77. Lau D. Mercaldo N. Harris A. Trittschuh E. Shega J. Weintraub S. (2010) Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Dis Assoc Disord 24: 56–63.
78. Lazarou J. Pomeranz B. Corey P. (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279: 1200–1205.
79. Leipzig R. Cumming R. Tinetti M. (1999a) Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 47: 30–39.
80. Leipzig R. Cumming R. Tinetti M. (1999b) Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 47: 40–50.
81. Leiss W. Mean M. Limacher A. Righini M. Jaeger K. Beer H. (2015) Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism. J Gen Intern Med 30: 17–24.
82. Liu C. Leung D. Chi I. (2011) Social functioning, polypharmacy and depression in older Chinese primary care patients. Aging Ment Health 15: 732–741.
83. Loganathan M. Singh S. Franklin B. Bottle A. Majeed A. (2011) Interventions to optimise prescribing in care homes: systematic review. Age Ageing 40: 150–162.
84. Lynch T. (2011) Management of drug–drug interactions: considerations for special populations–focus on opioid use in the elderly and long term care. Am J Manag Care 17(Suppl. 11): S293–S298.
85. Malhotra S. Karan R. Pandhi P. Jain S. (2001) Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 77: 703–707.
86. Mangoni A. Van Munster B. Woodman R. De Rooij S. (2013) Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am J Geriatr Psychiatry 21: 785–793.
87. Markson E. (1997) Functional, social, and psychological disability as causes of loss of weight and independence in older community-living people. Clin Geriatr Med 13: 639–652.
88. Martin P. Tamblyn R. Ahmed S. Tannenbaum C. (2013) A drug education tool developed for older adults changes knowledge, beliefs and risk perceptions about inappropriate benzodiazepine prescriptions in the elderly. Patient Educ Couns 92: 81–87.
89. Mate K. Kerr K. Pond D. Williams E. Marley J. Disler P. (2015) Impact of multiple low-level anticholinergic medications on anticholinergic load of community-dwelling elderly with and without dementia. Drugs Aging 32: 159–167.
90. McLeod P. Huang A. Tamblyn R. Gayton D. (1997) Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 156: 385–391.
91. Meador K. Taylor J. Thapa P. Fought R. Ray W. (1997) Predictors of antipsychotic withdrawal or dose reduction in a randomized controlled trial of provider education. J Am Geriatr Soc 45: 207–210.
92. Moore A. O–Keeffe S. (1999) Drug-induced cognitive impairment in the elderly. Drugs Aging 15: 15–28.
93. Moorhouse P. Mallery L. (2012) Palliative and therapeutic harmonization: a model for appropriate decision-making in frail older adults. J Am Geriatr Soc 60: 2326–2332.
94. Naugler C. Brymer C. Stolee P. Arcese Z. (2000) Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 7: 103–107.
95. Newman A. Yanez D. Harris T. Duxbury A. Enright P. Fried L. (2001) Weight change in old age and its association with mortality. J Am Geriatr Soc 49: 1309–1318.
96. Nguyen J. Fouts M. Kotabe S. Lo E. (2006) Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 4: 36–41.
97. Nishtala P. McLachlan A. Bell J. Chen T. (2008) Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 16: 621–632.
98. Nobili A. Marengoni A. Tettamanti M. Salerno F. Pasina L. Franchi C. (2011) Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur J Intern Med 22: 597–602.
99. Nuotio M. Jylha M. Luukkaala T. Tammela T. (2005) Health problems associated with lower urinary tract symptoms in older women. a population-based survey. Scand J Prim Health Care 23: 209–214.
100. O–Mahony D. Gallagher P. (2008) Inappropriate prescribing in the older population: need for new criteria. Age Ageing 37: 138–141.
101. O–Mahony D. O–Sullivan D. Byrne S. O–Connor M. Ryan C. Gallagher P. (2014) STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44: 213–218.
102. Olsson I. Curman B. Engfeldt P. (2010) Patient focused drug surveillance of elderly patients in nursing homes. Pharmacoepidemiol Drug Saf 19: 150–157.
103. Omori D. Potyk R. Kroenke K. (1991) The adverse effects of hospitalization on drug regimens. Arch Intern Med 151: 1562–1564.
104. Onder G. Pedone C. Landi F. Cesari M. Della Vedova C. Bernabei R. (2002) Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 50: 1962–1968.
105. Onder G. Van Der Cammen T. Petrovic M. Somers A. Rajkumar C. (2013) Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing 42: 284–291.
106. Osterberg L. Blaschke T. (2005) Adherence to medication. N Engl J Med 353: 487–497.
107. Ostini R. Hegney D. Jackson C. Tett S. (2012) Knowing how to stop: ceasing prescribing when the medicine is no longer required. J Manag Care Pharm 18: 68–72.
108. Pan H. Li C. Chen T. Su T. Wang K. (2014) Association of polypharmacy with fall-related fractures in older Taiwanese people: age- and gender-specific analyses. BMJ Open 4: e004428.
109. Pasina L. Djade C. Nobili A. Tettamanti M. Franchi C. Salerno F. (2013) Drug–drug interactions in a cohort of hospitalized elderly patients. Pharmacoepidemiol Drug Saf 22: 1054–1060.
110. Pedigo N. Jr (1994) Neurotransmitter receptor plasticity in aging. Life Sci 55: 1985–1991.
111. Pimlott N. Hux J. Wilson L. Kahan M. Li C. Rosser W. (2003) Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. CMAJ 168: 835–839.
112. Pirmohamed M. James S. Meakin S. Green C. Scott A. Walley T. (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329: 15–19.
113. Pitkälä K. Juola A. Kautiainen H. Soini H. Finne-Soveri U. Bell J. (2014) Education to reduce potentially harmful medication use among residents of assisted living facilities: a randomized controlled trial. J Am Med Dir Assoc 15: 892–898.
114. Qato D. Alexander G. Conti R. Johnson M. Schumm P. Lindau S. (2008) Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 300: 2867–2878.
115. Rahme E. Choquette D. Beaulieu M. Bessette L. Joseph L. Toubouti Y. (2005) Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population. Am J Med 118: 1262–1270.
116. Rancourt C. Moisan J. Baillargeon L. Verreault R. Laurin D. Gregoire J. (2004) Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr 4: 9.
117. Ray W. Taylor J. Meador K. Lichtenstein M. Griffin M. Fought R. (1993) Reducing antipsychotic drug use in nursing homes. A controlled trial of provider education. Arch Intern Med 153: 713–721.
118. Riechelmann R. Tannock I. Wang L. Saad E. Taback N. Krzyzanowska M. (2007) Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst 99: 592–600.
119. Roberts M. Stokes J. King M. Lynne T. Purdie D. Glasziou P. (2001) Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 51: 257–265.
120. Rognstad S. Brekke M. Fetveit A. Spigset O. Wyller T. Straand J. (2009) The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified DELPHI study. Scand J Prim Health Care 27: 153–159.
121. Rossini M. Viapiana O. Adami S. Idolazzi L. Buda S. Veronesi C. (2014) Medication use before and after hip fracture: a population-based cohort and case-control study. Drugs Aging 31: 547–553.
122. Rottenkolber D. Hasford J. Stausberg J. (2012) Costs of adverse drug events in German hospitals – a microcosting study. Value Health 15: 868–875.
123. Rovner B. Steele C. Shmuely Y. Folstein M. (1996) A randomized trial of dementia care in nursing homes. J Am Geriatr Soc 44: 7–13.
124. Rudolph J. Salow M. Angelini M. McGlinchey R. (2008) The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 168: 508–513.
125. Ruxton K. Woodman R. Mangoni A. (2015) Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: a systematic review and meta-analysis. Br J Clin Pharmacol 80: 209–220.
126. Salahudeen M. Duffull S. Nishtala P. (2014) Impact of anticholinergic discontinuation on cognitive outcomes in older people: a systematic review. Drugs Aging 31: 185–192.
127. Salazar J. Poon I. Nair M. (2007) Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf 6: 695–704.
128. Sampson G. (2009) Weight loss and malnutrition in the elderly – the shared role of GPS and APDS. Aust Fam Physician 38: 507–510.
129. Santibanez-Beltran S. Villarreal-Rios E. Galicia-Rodriguez L. Martinez-Gonzalez L. Vargas-Daza E. Ramos-Lopez J. (2013) [Economic cost of polypharmacy in the elderly in primary health care]. Rev Med Inst Mex Seguro Soc 51: 192–199.
130. Sato I. Akazawa M. (2013) Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study. Drug Healthc Patient Saf 5: 143–150.
131. Schmader K. Hanlon J. Landsman P. Samsa G. Lewis I. Weinberger M. (1997) Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother 31: 529–533.
132. Schmidt I. Claesson C. Westerholm B. Nilsson L. Svarstad B. (1998) The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 46: 77–82.
133. Schmidt L. Dalhoff K. (2002) Food–drug interactions. Drugs 62: 1481–1502.
134. Scott I. Anderson K. Freeman C. Stowasser D. (2014) First do no harm: a real need to deprescribe in older patients. Med J Aust 201: 390–392.
135. Scott I. Hilmer S. Reeve E. Potter K. Le Couteur D. Rigby D. (2015) Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 175: 827–834.
136. Sehgal V. Bajwa S. Sehgal R. Bajaj A. Khaira U. Kresse V. (2013) Polypharmacy and potentially inappropriate medication use as the precipitating factor in readmissions to the hospital. J Family Med Prim Care 2: 194–199.
137. Seidling H. Schmitt S. Bruckner T. Kaltschmidt J. Pruszydlo M. Senger C. (2010) Patient-specific electronic decision support reduces prescription of excessive doses. Qual Saf Health Care 19: e15.
138. Sengstock D. Zimmerman J. Williams B. Chang A. Landefeld C. Ahalt C. (2014) Addressing Polypharmacy & Improving Medication Adherence in Older Adults in Current Diagnosis and Treatment: Geriatrics 2e (Current Geriatric Diagnosis and Treatment). US: McGraw-Hill Education/Medical.
139. Sganga F. Vetrano D. Volpato S. Cherubini A. Ruggiero C. Corsonello A. (2014) Physical performance measures and polypharmacy among hospitalized older adults: results from the CRIME study. J Nutr Health Aging 18: 616–621.
140. Shekelle P. Maclean C. Morton S. Wenger N. (2001) ACOVE quality indicators. Ann Intern Med 135: 653–667.
141. Singh M. Papas A. (2014) Oral implications of polypharmacy in the elderly. Dent Clin North Am 58: 783–796.
142. Smalley W. Griffin M. (1996) The risks and costs of upper gastrointestinal disease attributable to NSAIDs. Gastroenterol Clin North Am 25: 373–396.
143. Spinewine A. Schmader K. Barber N. Hughes C. Lapane K. Swine C. (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370: 173–184.
144. Stark R. John J. Leidl R. (2011) Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: a modelling approach. BMC Health Serv Res 11: 9.
145. Stein C. Griffin M. Taylor J. Pichert J. Brandt K. Ray W. (2001) Educational program for nursing home physicians and staff to reduce use of non-steroidal anti-inflammatory drugs among nursing home residents: a randomized controlled trial. Med Care 39: 436–445.
146. Steinman M. Hanlon J. (2010) Managing medications in clinically complex elders: ‘there–s got to be a happy medium–. JAMA 304: 1592–1601.
147. Steinman M. Rosenthal G. Landefeld C. Bertenthal D. Kaboli P. (2009) Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing. Arch Intern Med 169: 1326–1332.
148. Stubbs B. Eggermont L. Soundy A. Probst M. Vandenbulcke M. Vancampfort D. (2014) What are the factors associated with physical activity (PA) participation in community dwelling adults with dementia? A systematic review of PA correlates. Arch Gerontol Geriatr 59: 195–203.
149. Talasz H. Lechleitner M. (2012) Polypharmacy and incontinence. Z Gerontol Geriatr 45: 464–467.
150. Thapa P. Gideon P. Cost T. Milam A. Ray W. (1998) Antidepressants and the risk of falls among nursing home residents. N Engl J Med 339: 875–882.
151. Thomsen L. Winterstein A. Sondergaard B. Haugbolle L. Melander A. (2007) Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 41: 1411–1426.
152. Tollefson G. Montague-Clouse J. Lancaster S. (1991) The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population. J Neuropsychiatry Clin Neurosci 3: 314–319.
153. Topinkova E. Baeyens J. Michel J. Lang P. (2012) Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging 29: 477–494.
154. Turnheim K. (2003) When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 38: 843–853.
155. Visvanathan R. Newbury J. Chapman I. (2004) Malnutrition in older people – screening and management strategies. Aust Fam Physician 33: 799–805.
156. Vogt-Ferrier N. (2010) Reviewing a complicated geriatric drug regimen. Eur Geriatr Med 1: 198–202.
157. Von Moltke L. Greenblatt D. Romach M. Sellers E. (2001) Cognitive toxicity of drugs used in the elderly. Dialogues Clin Neurosci 3: 181–190.
158. Wehling M. (2009) Multimorbidity and polypharmacy: how to reduce the harmful drug load and yet add needed drugs in the elderly? Proposal of a new drug classification: fit for the aged. J Am Geriatr Soc 57: 560–561.
159. Wilson N. Hilmer S. March L. Cameron I. Lord S. Seibel M. (2011) Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc 59: 875–880.
160. Wimmer B. Dent E. Bell J. Wiese M. Chapman I. Johnell K. (2014) Medication regimen complexity and unplanned hospital readmissions in older people. Ann Pharmacother 48: 1120–1128.
161. Wold R. Lopez S. Yau C. Butler L. Pareo-Tubbeh S. Waters D. (2005) Increasing trends in elderly persons– use of nonvitamin, nonmineral dietary supplements and concurrent use of medications. J Am Diet Assoc 105: 54–63.
162. Yamada H. Sugiyama T. Ashida T. Ohwaki H. Fujii J. (2001) Medication management skill and regimen compliance are deteriorated in the elderly even without obvious dementia. Yakugaku Zasshi 121: 187–190.
163. Yourman L. Concato J. Agostini J. (2008) Use of computer decision support interventions to improve medication prescribing in older adults: a systematic review. Am J Geriatr Pharmacother 6: 119–129.
164. Zadak Z. Hyspler R. Ticha A. Vlcek J. (2013) Polypharmacy and malnutrition. Curr Opin Clin Nutr Metab Care 16: 50–55.